Expand ONCY Menu
ONCY MENU

ONCY Latest Press Releases

-- December 16, 2025 --

Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards Globe Newswire 12:18 PM
Oncolytics Biotech Announces Promising Efficacy and Translational Data Supporting Pelareorep in KRAS-Mutant Metastatic Colorectal Cancer Business Wire 9:00 AM

-- December 15, 2025 --

THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis Globe Newswire 10:54 AM

-- December 12, 2025 --

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance PRNewswire 10:48 AM
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era Globe Newswire 10:31 AM

-- December 9, 2025 --

Oncolytics Biotech Reschedules Special Meeting of Shareholders to Change Jurisdiction of Incorporation to Nevada Business Wire 6:00 PM

-- December 6, 2025 --

THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality Globe Newswire 1:51 PM

-- December 3, 2025 --

UPDATE -- The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality Globe Newswire 3:31 PM
The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality Globe Newswire 12:51 PM

-- November 20, 2025 --

Oncolytics Biotech Provides Update on Special Meeting of Shareholders Business Wire 4:05 PM

-- November 19, 2025 --

Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B Globe Newswire 9:45 AM
Oncolytics Biotech Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer Business Wire 9:00 AM

-- November 4, 2025 --

Oncolytics Biotech Establishes Gastrointestinal Tumor Scientific Advisory Board to Advance Pelareorep as a Platform Immunotherapy Business Wire 8:00 AM

-- October 28, 2025 --

Oncolytics Biotech Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care PRNewswire 7:30 AM

-- October 20, 2025 --

Oncolytics Biotech Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada PRNewswire 9:01 AM

-- September 29, 2025 --

Oncolytics Biotech Announces Update for Potential First-Line Pancreatic Cancer Registration Study PRNewswire 8:31 AM

-- September 16, 2025 --

Oncolytics Biotech Provides Update on GOBLET Study Progress and U.S. Site Expansion PRNewswire 7:00 AM

-- September 8, 2025 --

Oncolytics Biotech Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions PRNewswire 7:00 AM

-- September 2, 2025 --

Oncolytics Biotech Provides Updated Clinical Safety Data for Pelareorep, Including Across Multiple Gastrointestinal Tumors PRNewswire 9:10 AM

-- August 28, 2025 --

Oncolytics Biotech Announces Upcoming Investor Conferences in September PRNewswire 8:30 AM

-- August 11, 2025 --

Oncolytics Biotech Announces Voting Results from the Annual General Meeting of Shareholders PRNewswire 4:55 PM

-- August 8, 2025 --

Oncolytics Biotech Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep PRNewswire 9:05 AM
Oncolytics Biotech Announces Voluntary Delisting from the Toronto Stock Exchange PRNewswire 9:00 AM

-- August 5, 2025 --

Oncolytics Biotech Announces Upcoming Annual General Meeting and Second Quarter Financial Results PRNewswire 8:30 AM

-- July 29, 2025 --

Oncolytics Biotech to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End PRNewswire 8:30 AM
Market Data Delayed 15 Minutes